JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB52945

Anti-Apolipoprotein A I antibody [EP1368Y]

4

(9 Reviews)

|

(57 Publications)

Anti-Apolipoprotein A I antibody [EP1368Y] (ab52945) is a rabbit monoclonal antibody detecting Apolipoprotein A I in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF, ELISA. Suitable for Human,.

- Biophysical QC for unrivalled batch-batch consistency
- Over 40 publications
- Trusted since 2007

View Alternative Names

Apolipoprotein A-I, Apo-AI, ApoA-I, Apolipoprotein A1, APOA1

11 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human liver tissue sections labeling Apolipoprotein A I with purified ab52945 at 1/100 dilution (1.95 µg/ml). Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

Flow Cytometry (Intracellular) - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)

Intracellular Flow Cytometry analysis of HepG2 (Human hepatocellular carcinoma epithelial cell) cells labeling Apolipoprotein A I with purified ab52945 at 1/20 dilution (10μg/ml) (red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluorr® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Immunocytochemistry/ Immunofluorescence - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)

Immunocytochemistry/ Immunofluorescence analysis of HepG2 (Human hepatocellular carcinoma epithelial cell) cells labeling Apolipoprotein A I with purified ab52945 at 1/250 dilution (0.8 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200 (2.5 μg/ml) dilution. Goat anti rabbit IgG (Alexa Fluor® 488 ab150077) was used as the secondary antibody at 1/1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)

ab52945 (unpurified) at 1/100 dilution staining Apolipoprotein A I in human liver by Immunohistochemistry Paraffin embedded tissue.

Immunocytochemistry/ Immunofluorescence - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)

ab52945 (unpurified) at 1/100 dilution staining Apolipoprotein A I in HEPG2 cells by Immunofluorescence.

Immunoprecipitation - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)
  • IP

Unknown

Immunoprecipitation - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)

ab52945 (purified) at 1/20 dilution (1ug) immunoprecipitating Apolipoprotein A I in Human fetal liver lysates.
Lane 1 : Human fetal liver lysates 10ug
Lane 2 (+) : ab52945 & Human fetal liver lysates
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab52945 in Human fetal liver lysates
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-Apolipoprotein A I antibody [EP1368Y] (ab52945)

Predicted band size: 30 kDa

false

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)
  • WB

Lab

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)

This blot was produced using 4-20% SDS-PAGE containing 15 μg of human liver lysate per lane at 150V for 1hr before being transferred onto a 0.45 μm PVDF membrane at 75V for 1hr. The membrane was then blocked for 1hr using 5% NFDM/TBST, then incubated with ab52945 (1/1000) at room temperature for 1hr. After being washed three times in TBST, the membrane was incubated with Peroxidase conjugated goat anti-rabbit IgG with minimal cross-reactivity with human IgG at 1/2000 dilution for 1hr at room temperature. The membrane was washed three times again. Then the signal was developed using the ECL technique. ab52945 was stored at a range of temperatures (+4°C, +22°C, +37°C) for 1 week before being tested in WB. The image shows the band intensity remains relatively constant across all storage temperatures, demonstrating that antibody activity is not affected.

All lanes:

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (ab52945) at 1/1000 dilution

All lanes:

Human liver lysate at 15 µg with NDFM/TBST

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/2000 dilution

false

Exposure time: 7s

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)
  • WB

Unknown

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)

All lanes:

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (ab52945) at 1/20000 dilution

All lanes:

fetal liver lysate at 10 µg

Secondary

All lanes:

goat anti-rabbit HRP at 1/2000 dilution

Predicted band size: 30 kDa

Observed band size: 31 kDa

false

Indirect ELISA - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)
  • I-ELISA

Lab

Indirect ELISA - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)

ELISA analysis of Apolipoprotein A I recombinant protein at 1000 ng/mL with ab52945 at 1000~0ng/mL. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution was used as the secondary antibody.

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)
  • WB

Lab

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)

All lanes:

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (ab52945) at 1/1000 dilution

All lanes:

HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysates at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 30 kDa

Observed band size: 31 kDa

false

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)
  • WB

Lab

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (AB52945)

All lanes:

Western blot - Anti-Apolipoprotein A I antibody [EP1368Y] (ab52945) at 1/1000 dilution

All lanes:

Human liver lysates at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 30 kDa

Observed band size: 31 kDa

false

  • Carrier free

    Anti-Apolipoprotein A I antibody [EP1368Y] - Low endotoxin, Azide free

  • Carrier free

    Anti-Apolipoprotein A I antibody [EP1368Y] - BSA and Azide free

  • 578 PE

    PE Anti-Apolipoprotein A I antibody [EP1368Y]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Apolipoprotein A I antibody [EP1368Y]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Apolipoprotein A I antibody [EP1368Y]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP1368Y

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, WB, ELISA, ICC/IF, IHC-P, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/60", "IP-species-notes": "<p></p>", "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>For unpurified use at 1/20000 dilution.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/20", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Synthetic peptide": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "ELISA-species-checked": "testedAndGuaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p>Antibody conc. = 0 - 1000 ng/ml</p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-Apolipoprotein A I antibody [EP1368Y] (ab52945) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF), ELISA in Human, samples.

What is the molecular weight of Apolipoprotein A I?
Anti-Apolipoprotein A I [EP1368Y] (ab52945) specifically detects a band for Apolipoprotein A I (UniProt: P02647) at a molecular weight of 31kDa.

Trusted by the scientific community
Anti-Apolipoprotein A I [EP1368Y] (ab52945) was first used in a scientific publication in 2007 and has been cited over 40 times in peer-reviewed journals.

Reviewed by scientists
Anti-Apolipoprotein A I [EP1368Y] (ab52945) has over 5 independent reviews from customers.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [EP1368Y] also available for your convenience: ab52945, Carrier free - ab185132, Carrier free - ab271849, Alexa Fluor® 488 - ab279676, Alexa Fluor® 647 - ab279677, PE - ab282174

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Shipping conditions update: ambient shipping

This product will be delivered at ambient temperature instead of chilled – this is by design. Extensive stability testing confirmed that our products are suitable for shipment under ambient conditions and maintain expected quality.

Why the change?

It’s part of our commitment to more sustainable packaging solutions, with ambient deliveries using eco-friendly materials such as recyclable cardboard instead of polystyrene.

What you need to know

  • Ambient shipments come clearly marked on the delivery note.
  • No ice will be included in ambient shipments, but mixed orders (ambient and cold-chain items) will still arrive with ice packs to protect temperature-sensitive products.
  • Warranty coverage remains fully valid, aligned with our validated shipping method.
  • Please store the product as per the datasheet instructions upon receipt.

Find out more - https://www.abcam.com/en-us/support/shipping-storage-support/ambient-shipping

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Apolipoprotein A-I (ApoA-I) is a major component of high-density lipoprotein (HDL) particles often referred to as 'good cholesterol'. It has a molecular mass of approximately 28 kDa. ApoA-I is mainly expressed in the liver and intestine. It plays a mechanical role in the reverse transport of cholesterol acting to facilitate the efflux of cholesterol from tissues to the liver for excretion. Its alternative names include ApoAI ApoA1 and a component of the AI kits used for measuring this protein.
Biological function summary

ApoA-I functions in cholesterol homeostasis and inflammation. It is a structural component of the HDL complex that mobilizes cholesterol. ApoA-I acts as an activator of the enzyme lecithin-cholesterol acyltransferase (LCAT) which is essential for the maturation of HDL particles. This maturation is necessary for effective cholesterol transport and clearance. ApoA-I's ability to stabilize HDL particles and enhance their functionality makes it significant for maintaining lipid balance and cellular homeostasis.

Pathways

The interaction of ApoA-I with HDL formation and function marks its role in lipid metabolism pathways. Its participation in the reverse cholesterol transport pathway highlights its influence on cardiovascular health. ApoA-I also interacts with other proteins like ApoA-II and paraoxonase-1 which further influence lipid metabolism and antioxidant activities. Understanding these relationships helps elucidate the dynamics of cholesterol removal from the bloodstream.

Disturbances in ApoA-I levels correlate with cardiovascular disease and atherosclerosis. Deficiency or dysfunction in ApoA-I can impair HDL function leading to poor cholesterol removal and buildup within arteries. It is also connected to amyloidosis where misfolded ApoA-I forms deposits in tissues. Understanding these pathological conditions helps researchers target ApoA-I in therapeutic strategies to mitigate disease progression often studying it alongside proteins like ApoB which is associated with low-density lipoprotein (LDL) particles.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility.
See full target information APOA1

Publications (57)

Recent publications for all applications. Explore the full list and refine your search

Precision clinical medicine 8:pbaf014 PubMed40657162

2025

Decoding hepatobiliary-specific immune gene patterns in gastrointestinal cancers via gene ontology fingerprints, multi-omics, and experimental integration.

Applications

Unspecified application

Species

Unspecified reactive species

Honglian Huang,Yueping Zhan,Hui Zong,Chenjun Huang,Fan Yang,Ziyi Wei,Xin Qin,M James C Crabbe,Ying Wang,Xiaoyan Zhang

Journal of extracellular vesicles 14:e70058 PubMed40108918

2025

Next Generation Aqueous Two-Phase System for Gentle, Effective, and Timely Extracellular Vesicle Isolation and Transcriptomic Analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Boyang Su,Morteza Jeyhani,Gobi Thillainadesan,Minzhi Sheng,Reese Wunsche,Thamara Dayarathna,Kristin Cimolai,Hanyi Weng,Katarzyna J Jerzak,Stanley K Liu,Scott S H Tsai,Hon S Leong

Atherosclerosis plus 59:32-38 PubMed39811778

2025

HDL-associated vitamin D binding protein levels are inversely associated with necrotic plaque burden in psoriasis.

Applications

Unspecified application

Species

Unspecified reactive species

M P Playford,H Li,A K Dey,E M Florida,H L Teague,S M Gordon,N N Mehta

Molecular therapy. Methods & clinical development 32:101353 PubMed39512906

2024

Large and small extracellular vesicles from Wharton's jelly MSCs: Biophysics, function, and strategies to improve immunomodulation.

Applications

Unspecified application

Species

Unspecified reactive species

July Constanza Buitrago,Mónica Cruz-Barrera,Valerie Dorsant-Ardón,Carlos Medina,David G Hernández-Mejía,Karl Beltrán,Natalia Flórez,Bernardo Camacho,Jens Gruber,Gustavo Salguero

Scientific reports 14:24098 PubMed39407038

2024

Unveiling the Immunomodulatory and regenerative potential of iPSC-derived mesenchymal stromal cells and their extracellular vesicles.

Applications

Unspecified application

Species

Unspecified reactive species

July Constanza Buitrago,Sarah L Morris,Astrid Backhaus,Gesa Kaltenecker,Jagan Mohan Kaipa,Cyrille Girard,Stefan Schneider,Jens Gruber

Bioactive materials 40:683-695 PubMed39290685

2024

High throughput and rapid isolation of extracellular vesicles and exosomes with purity using size exclusion liquid chromatography.

Applications

Unspecified application

Species

Unspecified reactive species

Kshipra S Kapoor,Kristen Harris,Kent A Arian,Lihua Ma,Beatriz Schueng Zancanela,Kaira A Church,Kathleen M McAndrews,Raghu Kalluri

Journal of proteome research 23:4114-4127 PubMed39141927

2024

Defining the Soluble and Extracellular Vesicle Protein Compartments of Plasma Using In-Depth Mass Spectrometry-Based Proteomics.

Applications

Unspecified application

Species

Unspecified reactive species

Nidhi Sharma,Silvia Angori,AnnSofi Sandberg,Georgios Mermelekas,Janne Lehtiö,Oscar P B Wiklander,André Görgens,Samir El Andaloussi,Hanna Eriksson,Maria Pernemalm

Scientific reports 13:20019 PubMed37973808

2023

Transthyretin amyloid deposition in ligamentum flavum (LF) is significantly correlated with LF and epidural fat hypertrophy in patients with lumbar spinal stenosis.

Applications

Unspecified application

Species

Unspecified reactive species

Kazuya Maeda,Kazuki Sugimoto,Masayoshi Tasaki,Takuya Taniwaki,Takahiro Arima,Yuto Shibata,Makoto Tateyama,Tatsuki Karasugi,Takanao Sueyoshi,Tetsuro Masuda,Yusuke Uehara,Takuya Tokunaga,Satoshi Hisanaga,Masaki Yugami,Ryuji Yonemitsu,Katsumasa Ideo,Kozo Matsushita,Yuko Fukuma,Masaru Uragami,Junki Kawakami,Naoto Yoshimura,Kosei Takata,Masaki Shimada,Shuntaro Tanimura,Hideto Matsunaga,Yuki Kai,Shu Takata,Ryuta Kubo,Rui Tajiri,Fuka Homma,Xiao Tian,Mitsuharu Ueda,Takayuki Nakamura,Takeshi Miyamoto

STAR protocols 4:102515 PubMed37742179

2023

Proteomics protocol for obtaining extracellular vesicle from human plasma using asymmetrical flow field-flow fractionation technology.

Applications

Unspecified application

Species

Unspecified reactive species

Na Li,Yumeng Yan,Bowen Wu,Jifeng Wang,Fuquan Yang

PloS one 18:e0291623 PubMed37708210

2023

Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Morten Lapin,Kjersti Tjensvoll,Karoline Nedrebø,Eline Taksdal,Hans Janssen,Bjørnar Gilje,Oddmund Nordgård
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com